CVRx (CVRX) Competitors $7.85 -0.03 (-0.38%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$7.84 -0.01 (-0.19%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CVRX vs. TNDM, AXGN, SIBN, BVS, ZIMV, AVNS, SMLR, KIDS, CBLL, and TMCIShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include Tandem Diabetes Care (TNDM), AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), Semler Scientific (SMLR), OrthoPediatrics (KIDS), CeriBell (CBLL), and Treace Medical Concepts (TMCI). These companies are all part of the "medical equipment" industry. CVRx vs. Its Competitors Tandem Diabetes Care AxoGen SiBone Bioventus ZimVie AVANOS MEDICAL Semler Scientific OrthoPediatrics CeriBell Treace Medical Concepts Tandem Diabetes Care (NASDAQ:TNDM) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations. Is TNDM or CVRX more profitable? Tandem Diabetes Care has a net margin of -20.51% compared to CVRx's net margin of -95.61%. Tandem Diabetes Care's return on equity of -65.40% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets Tandem Diabetes Care-20.51% -65.40% -13.87% CVRx -95.61%-79.31%-40.96% Do analysts rate TNDM or CVRX? Tandem Diabetes Care currently has a consensus price target of $22.47, suggesting a potential upside of 79.59%. CVRx has a consensus price target of $14.00, suggesting a potential upside of 78.34%. Given Tandem Diabetes Care's higher probable upside, analysts plainly believe Tandem Diabetes Care is more favorable than CVRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tandem Diabetes Care 0 Sell rating(s) 11 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.27CVRx 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86 Does the media refer more to TNDM or CVRX? In the previous week, Tandem Diabetes Care had 5 more articles in the media than CVRx. MarketBeat recorded 6 mentions for Tandem Diabetes Care and 1 mentions for CVRx. CVRx's average media sentiment score of 1.87 beat Tandem Diabetes Care's score of 1.73 indicating that CVRx is being referred to more favorably in the news media. Company Overall Sentiment Tandem Diabetes Care Very Positive CVRx Very Positive Which has higher earnings & valuation, TNDM or CVRX? CVRx has lower revenue, but higher earnings than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTandem Diabetes Care$940.20M0.90-$96.03M-$3.09-4.05CVRx$51.29M4.00-$59.97M-$2.10-3.74 Which has more risk & volatility, TNDM or CVRX? Tandem Diabetes Care has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Comparatively, CVRx has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Do insiders and institutionals have more ownership in TNDM or CVRX? 75.3% of CVRx shares are held by institutional investors. 1.9% of Tandem Diabetes Care shares are held by insiders. Comparatively, 13.9% of CVRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryCVRx beats Tandem Diabetes Care on 10 of the 17 factors compared between the two stocks. Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$205.29M$7.16B$5.75B$9.76BDividend YieldN/A1.19%4.10%4.04%P/E Ratio-3.7426.1883.2726.59Price / Sales4.0055.36535.03111.31Price / CashN/A21.7237.4459.26Price / Book3.547.0910.556.58Net Income-$59.97M$176.42M$3.27B$265.95M7 Day Performance0.64%0.83%0.40%0.17%1 Month Performance-1.38%3.53%7.31%3.90%1 Year Performance-20.39%7.54%46.58%19.67% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx2.491 of 5 stars$7.85-0.4%$14.00+78.3%-20.4%$205.29M$51.29M-3.74160Positive NewsTNDMTandem Diabetes Care4.5058 of 5 stars$10.84+0.2%$22.67+109.1%-71.2%$731.10M$940.20M-3.512,650AXGNAxoGen2.4363 of 5 stars$15.49+3.8%$26.00+67.9%+22.7%$686.97M$203.27M-154.88450News CoverageSIBNSiBone4.3453 of 5 stars$15.54+0.5%$23.67+52.3%+0.3%$666.96M$167.18M-27.75350News CoveragePositive NewsBVSBioventusN/A$7.18-2.6%N/AN/A$609.34M$573.28M14.741,200ZIMVZimVie0.6004 of 5 stars$18.95+0.5%$17.75-6.3%+8.9%$531.59M$449.75M-27.071,770News CoveragePositive NewsAVNSAVANOS MEDICAL3.2743 of 5 stars$11.24+0.4%N/A-50.7%$519.71M$687.80M-1.122,227News CoveragePositive NewsAnalyst RevisionSMLRSemler Scientific3.2364 of 5 stars$33.76-0.2%$81.75+142.2%+11.0%$500.99M$56.29M13.89120News CoverageKIDSOrthoPediatrics4.3401 of 5 stars$19.20+0.1%$34.14+77.8%-33.1%$481.17M$220.73M-10.73200Positive NewsCBLLCeriBell2.4303 of 5 stars$12.18-1.1%$32.14+163.9%N/A$451.33M$65.44M-4.07N/ANews CoverageTMCITreace Medical Concepts2.2075 of 5 stars$7.04+2.2%$9.83+39.7%+19.0%$435.26M$209.36M-8.91250News Coverage Related Companies and Tools Related Companies TNDM Competitors AXGN Competitors SIBN Competitors BVS Competitors ZIMV Competitors AVNS Competitors SMLR Competitors KIDS Competitors CBLL Competitors TMCI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CVRX) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CVRX Stock Alerts